Non-steroidal analogs of 1,25-dihydroxyvitamin D 3 [1, 25(OH) 2 D 3 ] represent a most particular class of analogs because they are either not directly derived from the core 1,25(OH) 2 D 3 -structure or they have modifications in the core structure that are so drastic that the steroidal structure is lost. Non-steroidal CD-ring analogs of 1,25(OH) 2 
INTRODUCTION
1,25-Dihydroxyvitamin D 3 [1, 25(OH) 2 D 3 ] is a key regulator of calcium/phosphate levels and bone maintenance and acts through the Vitamin D Receptor (VDR), a member of the nuclear receptor superfamily, which can heterodimerize with the Retinoid X Receptor (RXR) and binds to Vitamin D Response Elements (VDREs) in the promoter region of target genes [1] . Beside the actions on calcium and bone, 1,25(OH) 2 D 3 has a potent growthinhibitory or antiproliferative and prodifferentiating action on different cell types including malignant cancer cells, mostly characterized by a G1/S arrest in the cell cycle [2] . It has become clear that, depending on the cell type, 1,25(OH) 2 D 3 can use different pathways or combinations of pathways to establish its antiproliferative effect. Cyclins, cyclin dependent kinases (CDKs), CDK inhibitors, E2F transcription factors and their binding partners from the Retinoblastoma family are mostly the point of convergence between the different pathways [3] .
In theory, its potent antiproliferative action combined with the presence of the VDR in a large array of cell types, would make 1,25(OH) 2 D 3 a powerful drug to treat hyperproliferative disorders. However, the calcemic actions obstruct the clinical applicability of 1,25(OH) 2 D 3 . Administration of the required doses to fully benefit from the antiproliferative action, can result in severe hypercalcemia, hypercalciuria and bone resorption. even all three of these target regions [3] . Here we review a particular class of non-steroidal analogs which were developed in order to study the importance of the less accessible CD-ring system in the biological actions of 1,25(OH) 2 D 3 .
NON-STEROIDAL CD-RING ANALOGS OF 1,25(OH) 2 D 3
Different series of CD-ring modified analogs of 1,25(OH) 2 D 3 have been designed among which analogs in which the steroidal structure was lost due to the drastic changes in this ring structure ( Figure 1 ). The most basic nonsteroidal compound is the acyclic analog KS018 in which 1,25(OH) 2 D 3 is completely stripped to its five carbon backbone. KS018 does not bind to the VDR and lacks all biological activity. Introduction of an unnatural, fivemembered 'E-ring' in KS018 (analog KS176) resulted in 10% VDR binding (in comparison with 1,25(OH) 2 D 3 ), minor antiproliferative action and negligible calcemic effects [4] . Remarkably, re-introduction of the sixmembered C-ring (15-nor C-ring analogs e.g. ZG1368) or the five-membered D-ring (9,11-bisnor D-ring analogs e.g. SL117) generally results in an increased dissociation ratio between antiproliferative potency and calcemic effects in comparison with 1,25(OH) 2 D 3 [5] . As such the D-ring analog WU515, which has an additional 23-yne-26,27-F 6 modification, displays an 800-fold increased antiproliferative/calcemic ratio. The best selectivity profile within the C-and D-ring analogs is obtained with the 19-nor-16-ene-26,27-bishomo Cring analog CY616 for which the antiproliferative/calcemic ratio is 1200-fold higher than for 1,25(OH) 2 D 3 [5] .
The CE-ring and CF-ring analogs represent two additional classes of non-steroidal analogs in which the D-ring has been deleted and a connection was made between C12 and C21 or between C18 and C21, respectively. The CE-ring analogs (eg. analogs XU248 and SD65) have very low or do not display antiproliferative actions on MCF-7 human breast cancer cells. The CF-ring analogs (eg. SW123) have low VDR affinity (<10%) as well as low calcemic actions (<1%) in comparison with 1,25(OH) 2 D 3 [6, 7] . SW123 is five times more potent in inhibiting MCF-7 cell proliferation and is more than 200 times less calcemic than 1,25(OH) 2 D 3 . The introduction of a 22-oxa-23-yne-26,27-F 6 side chain (analog FDB198E) further enhanced the antiproliferative action and reduced the calcemic effects of SW123 [8] .
SUPERAGONISTIC ACTION OF D-RING ANALOGS CD578, WU515 AND WY1113
Recently, we determined the actions of the three potent non-steroidal D-ring analogs CD578 (17-methyl-19-nor-21-nor-23-yne-26,27- (Table 1) . CD578, WU515 and WY1113 are fluorinated on C26 and C27 of the side chain, a chemical modification that is often used to make analogs of 1,25(OH) 2 D 3 more resistant to degradation by CYP24; a C-F bond better withstands cleavage and radical oxidation than a C-H bond. The basic fluorinated analog 26,27-F 6 -1,25(OH) 2 D 3 (falecalcitriol) was shown to be resistant to CYP24-mediated catabolism and had a higher T 1/2 than the parent compound [11] . Both antiproliferative and calcemic actions are tenfold more potent for falecalcitriol. The abovementioned stronger VDR -coactivator interactions for CD578, WU515 and WY1113 could not be explained by differences in resistance to catabolism between the three analogs and 1,25(OH) 2 
CONCLUSIONS
The non-steroidal CD-ring analogs of 1,25(OH) 2 D 3 are an ultimate tool to study the impact of drastic changes at the CD-ring system, and of the combination of changes at the CD-ring with other modifications, on the biological activity of 1,25(OH) 2 D 3 . The D-ring analogs CD578, WU515 and WY1113, for example, show a significantly stronger differentiating action on human colon cancer cells caused by a stronger inhibition of β-catenin/TCF signaling and more potent induction of VDR-coactivator interactions. In addition, the side chain fluorine atoms on these three analogs not only protect them from CYP24-mediated metabolic degradation but also contribute to increased stability of the activation H12 of the VDR. In addition to the most basic non-steroidal, acyclic analog KS018 five different classes of non-steroidal analogs are shown with drastic modifications in the CD-ring system. For each class first an analog with the natural Aring and natural side chain is shown (except for analog SW123 which has a 19-nor A-ring structure). Further down are analogs with additional A-ring or side chain modifications.
